KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy

ANTONIO RIVERO ROMÁN2026-01-292026-01-29201710.1038/tpj.2016.192-s2.0-84961226601https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/26964GeneticsMolecular MedicinePharmacologyKIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapyresearch article